Uncategorised - European Medical Journal

Measles Outbreak Drives Vaccine Push in London - EMJ

Measles Outbreak Drives Push for Vaccination in London

London measles outbreak prompts calls for stronger vaccination efforts, with low uptake and inequalities driving rising case numbers.

Clinician discussing ADHD care for a school-aged child with a parent, highlighting coordination between healthcare and schools.

ADHD Services Often Lack School Coordination

Many ADHD care providers for children report school coordination gaps, with training and barriers shaping support.

Cancer survivor using a mobile nutrition app to track diet and support quality of life after treatment

Mobile Nutrition App Improves Diet in Patients with Cancer

A mobile nutrition app improved dietary moderation and appetite loss outcomes in patients with cancer over 4 weeks.

Telemedicine Reduces MASLD Risk in Adults with Diabetes - EMJ

Telemedicine Reduces MASLD Risk in Adults with Diabetes

Telemedicine nutrition care reduces MASLD and liver disease risk in adults with type 2 diabetes and obesity, showing promise for lifestyle-first interventions.

Novel MRI Boosts Detection of Stroke-Causing Plaques – EMJ

Novel MRI Boosts Detection of Stroke-Causing Plaques

New vessel wall MRI detects more supracardiac atherosclerosis plaques than CTA, improving stroke evaluation and identifying embolic sources.

Biomarker Discovery Reframes Schizophrenia Treatment

A single administration of SEAD1 into the prefrontal cortex restored disrupted E/I balance and improved synaptic function.

AI Uses Eye-Tracking Technology to Diagnose Autism

AI can distinguish children with autism spectrum disorder using eye-tracking technology with an accuracy of 85%, a 2026 systematic review has found.

More Than One Million People to be Offered Semaglutide on NHS

Semaglutide is set to be offered to more than one million people with cardiovascular disease on the NHS in coming months.

Eli Lilly office building

Lilly’s weight loss pill wins FDA approval

Eli Lilly won FDA approval on 1 April 2026 for a once-daily oral GLP-1, orforglipron.

Urinary Metabolites Identify Bladder Cancer and Predict Recurrence

Urinary metabolites may help detect bladder cancer and predict recurrence, offering a potential non-invasive tool to improve patient monitoring and outcomes.